ThermoGenesis Announces Major Strategic Development With Completion of New Distribution Agreement With GE Healthcare

RANCHO CORDOVA, Calif., Feb. 4 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, today announced a new enhanced distribution agreement with GE Healthcare, a unit of General Electric Company (NYSE: GE), for its AXP® AutoXpress ™ (AXP) System used in the processing of cord blood.

MORE ON THIS TOPIC